Published in Toxicol Appl Pharmacol on February 01, 1977
Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev (1990) 1.26
Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J Pharmacol Exp Ther (2000) 1.23
Cyclic adenosine monophosphate antagonism of morphine analgesia. J Pharmacol Exp Ther (1973) 1.23
Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs. Drug Metab Dispos (1983) 1.17
Sensitivity of fish ATPases to polychlorinated biphenyls. Nature (1971) 1.11
Pharmacological manipulation of gamma-aminobutyric acid (GABA) in morphine analgesia, tolerance and physical dependence. Life Sci (1976) 1.08
A review of the role of tissue repair as an adaptive strategy: why low doses are often non-toxic and why high doses can be fatal. Food Chem Toxicol (1996) 1.05
Role of hepatocellular regeneration in CCl4 autoprotection. Toxicol Pathol (1991) 1.02
Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial. Osteoporos Int (2006) 1.02
Interactions of ginsenosides with ligand-bindings of GABA(A) and GABA(B) receptors. Gen Pharmacol (1994) 1.01
Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. Drug Metab Dispos (2001) 1.01
Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes. Crit Rev Toxicol (2007) 1.00
Effects of acute and continuous morphine administration on catecholamine-sensitive adenosine triphosphatase in mouse brain. J Pharmacol Exp Ther (1979) 0.98
Mechanism of action of barbiturates. Annu Rev Pharmacol Toxicol (1981) 0.97
Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice. Neurology (1998) 0.97
Physiologically based pharmacokinetic/pharmacodynamic modeling of the toxicologic interaction between carbon tetrachloride and Kepone. Arch Toxicol (1996) 0.95
Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology (1995) 0.95
Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res (1994) 0.95
Perinatal lead exposure alters the expression of neuronal nitric oxide synthase in rat brain. Int J Toxicol (2001) 0.94
Potentiation of CCl4 hepatotoxicity and lethality by chlordecone in female rats. Toxicology (1983) 0.94
PB-PK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital, or mirex. Toxicol Appl Pharmacol (1991) 0.94
G2 subpopulation in rat liver induced into mitosis by low-level exposure to carbon tetrachloride: an adaptive response. Toxicol Appl Pharmacol (1993) 0.92
Severe hypoxia produced by concomitant intoxication with sublethal doses of carbon monoxide and cyanide. Toxicol Appl Pharmacol (1991) 0.92
Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ Health Perspect (1995) 0.92
Hepatic cell division and tissue repair: a key to survival after liver injury. Mol Med Today (1996) 0.90
Hepatic uptake and disposition of aflatoxin B1 in isolated perfused rat liver. Toxicol Appl Pharmacol (1977) 0.89
Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a light and electron microscopic study. Exp Mol Pathol (1983) 0.89
Changes in the central dopaminergic systems in the streptozotocin-induced diabetic rats. Arch Pharm Res (1994) 0.89
Mechanisms of increased liver tissue repair and survival in diet-restricted rats treated with equitoxic doses of thioacetamide. Toxicol Sci (2003) 0.88
Kinetics of catecholamine sensitive Na+-K+ ATPase activity in mouse brain synaptosomes. Biochem Pharmacol (1977) 0.88
Potentiation of the hepatotoxicity of carbon tetrachloride following preexposure to chlordecone (kepone) in the male rat. Toxicol Appl Pharmacol (1979) 0.87
Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol Appl Pharmacol (2000) 0.87
Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a morphometric and biochemical study. Exp Mol Pathol (1983) 0.87
Brain 5-hydroxytryptamine and cyclic AMP in morphine tolerance and dependence. Adv Biochem Psychopharmacol (1974) 0.87
Triton solubilized acetylcholinesterase of brain. J Neurochem (1969) 0.87
Fire ant venom alkaloid, isosolenopsin A, a potent and selective inhibitor of neuronal nitric oxide synthase. Int J Toxicol (2003) 0.87
Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Neurochem Int (2001) 0.86
Marine biomolecules inhibit rat brain nitric oxide synthase activity. Toxicology (1998) 0.86
Protection of hepatotoxic and lethal effects of CCl4 by partial hepatectomy. Toxicol Pathol (1989) 0.86
Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride. Biol Pharm Bull (1999) 0.86
Sensitivity to continuous administration of pentobarbital in different strains of mice. Res Commun Chem Pathol Pharmacol (1978) 0.86
Tissue injury and repair as parallel and opposing responses to CCl4 hepatotoxicity: a novel dose-response. Toxicology (1997) 0.86
Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther (1988) 0.86
Potentiation of halomethane hepatotoxicity: chlordecone and carbon tetrachloride. Fundam Appl Toxicol (1984) 0.86
Potentiation of CCl4 lethality by chlordecone. Toxicol Lett (1982) 0.85
Colchicine antimitosis abolishes CCl4 autoprotection. Toxicol Pathol (1991) 0.85
Influence of p-chlorophenylalanine on morphine tolerance and physical dependence and regional brain serotonin turnover studies in morphine tolerant-dependent mice. J Pharmacol Exp Ther (1972) 0.85
Inhibition of Ca2+ transport associated with cAMP-dependent protein phosphorylation in rat cardiac sarcoplasmic reticulum by triorganotins. Arch Toxicol (1991) 0.85
Selective inhibitory effect of organophosphates on UDP-glucuronyl transferase activities in rat liver microsomes. Biochem Pharmacol (1986) 0.85
Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur J Pharmacol (1996) 0.85
A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception. Eur J Pharmacol (1994) 0.85
Barbiturates and the GABAA receptor complex. Prog Drug Res (1990) 0.85
Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8. Eur J Pharmacol (1995) 0.85
Polychlorinated biphenyls: effect of long-term exposure on ATPase activity in fish, Pimephales promelas. Bull Environ Contam Toxicol (1974) 0.84
A quantitative histochemistry technique for measuring regional distribution of acetylcholinesterase in the brain using digital scanning densitometry. Anal Biochem (2001) 0.84
Temporal changes in tissue repair permit survival of diet-restricted rats from an acute lethal dose of thioacetamide. Toxicol Sci (1998) 0.84
Inhibition of spider mite ATPases by plictran and three organochlorine acaricides. Life Sci (1973) 0.84
GABA in morphine analgesia and tolerance. Life Sci (1985) 0.83
Suppression of cellular immune responses in BALB/c mice following oral exposure to permethrin. Bull Environ Contam Toxicol (1995) 0.83
Nutritional impact on the final outcome of liver injury inflicted by model hepatotoxicants: effect of glucose loading. FASEB J (1995) 0.83
Region specific increase of dopamine receptor D1/D2 mRNA expression in the brain of mu-opioid receptor knockout mice. Brain Res (2001) 0.83
Effects of blockade of Kupffer cells by gadolinium chloride on hepatobiliary function in cold ischemia-reperfusion injury of rat liver. Hepatology (1997) 0.83
In situ hybridization evidence of differential modulation by pentobarbital of GABAA receptor alpha 1- and beta 3-subunit mRNAs. J Neurochem (1994) 0.83
Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice. Brain Res Bull (2000) 0.83
Comparative pharmacological and biochemical studies between butorphanol and morphine. Pharmacol Biochem Behav (1989) 0.83
Effects of rubratoxin B on the kinetics of cationic and substrate activation of (Na+-K+)-ATPase and p-nitrophenyl phosphatase. J Biol Chem (1978) 0.83
Acute and chronic effects of pentobarbital in relation to postsynaptic GABA receptors: a study with muscimol. J Neurosci Res (1982) 0.83
Nutritional modulation of the final outcome of hepatotoxic injury by energy substrates: an hypothesis for the mechanism. Med Hypotheses (1996) 0.82
The in vitro sensitivity of fish brain ATPases to organochlorine acaricides. Life Sci II (1972) 0.82
Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis. Biochim Biophys Acta (1989) 0.82
Inhibition of oligomycin-sensitive and -insensitive magnesium adenosine triphosphatase activity in fish by polychlorinated biphenyls. Biochem Pharmacol (1972) 0.82
Two-dimensional electrophoretic analysis of compartment-specific hepatic protein charge modification induced by thioacetamide exposure in rats. Fundam Appl Toxicol (1996) 0.82
Excessive hepatic accumulation of intracellular Ca2+ in chlordecone potentiated CCl4 toxicity. Toxicology (1984) 0.82
Effects of chronic lead (Pb) exposure on neurobehavioral function and dopaminergic neurotransmitter receptors in rats. Toxicol Lett (1999) 0.82
Decreased paralysis and better motor coordination with microspinal versus PE10 intrathecal catheters in pain study rats. Anesth Analg (1997) 0.82
Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment. Eur J Pharmacol (1999) 0.82
Effects of single or repeated dermal exposure to methyl parathion on behavior and blood cholinesterase activity in rats. J Biomed Sci (2001) 0.82
Effects of chronic administration of pentobarbital or morphine on the brain microsomal cytochrome P-450 system. Biochem Pharmacol (1981) 0.81
Amitriptyline prevents N-methyl-D-aspartate (NMDA)-induced toxicity, does not prevent NMDA-induced elevations of extracellular glutamate, but augments kainate-induced elevations of glutamate. J Neurochem (1992) 0.81
Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats. Brain Res (1996) 0.81
Metal inhibition of calmodulin activity in monkey brain. J Appl Toxicol (1989) 0.81
Efficient tissue repair underlies the resiliency of postnatally developing rats to chlordecone + CCl4 hepatotoxicity. Toxicology (1996) 0.81
Role of hepatocellular regeneration in chlordecone potentiated hepatotoxicity of carbon tetrachloride. Arch Toxicol (1989) 0.81
Tetradifon (tedion R ): a specific inhibitor of Mg 2+ dependent mitochondrial adenosine triphosphatase activity. Life Sci II (1972) 0.81
Effect of antimitotic agent colchicine on carbon tetrachloride toxicity. Arch Toxicol (1993) 0.81
Effects of nor-binaltorphimine on butorphanol dependence. Eur J Pharmacol (1993) 0.81
Hepatic microsomal metabolism of CCL4 after pretreatment with chlordecone, mirex, or phenobarbital in male rats. Drug Metab Dispos (1983) 0.81
Differences in morphine-induced antinociception and locomotor activity in mature adult and aged mice. Pharmacol Biochem Behav (1986) 0.81
Pharmacology of barbiturate tolerance/dependence: GABAA receptors and molecular aspects. Life Sci (1996) 0.80
Protection from CCl4 toxicity by prestimulation of hepatocellular regeneration in partially hepatectomized gerbils. Biochem Pharmacol (1991) 0.80
Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol. Eur J Pharmacol (1994) 0.80
Effects of acute and continuous pentobarbital administration on the gamma-aminobutyric acid system. Biochem Pharmacol (1977) 0.80
Development of dispositional tolerance to phencyclidine by osmotic minipump in the mouse. J Pharmacol Methods (1982) 0.80
Inhibition of ATPases by gymnemic acid. Chem Biol Interact (1973) 0.80
Contribution of glutamatergic systems in locus coeruleus to nucleus paragigantocellularis stimulation-evoked behavior. Pharmacol Biochem Behav (1999) 0.80
Effect of amiodarone on Na+-, K+-ATPase and Mg2+-ATPase activities in rat brain synaptosomes. Cell Biochem Funct (1986) 0.80
Resiliency to amplification of carbon tetrachloride hepatotoxicity by chlordecone during postnatal development in rats. Pediatr Res (1993) 0.80